Journal of the American Academy of Child & Adolescent Psychiatry
Volume 45, Issue 9 , Pages 1138-1141, September 2006

Pharmacological Management of a Youth With ADHD, Marijuana Use, and Mood Symptoms

Dr. Kratochvil is with the Department of Psychiatry, University of Nebraska Medical Center, Omaha; Dr. Wilens is with the Pediatric Psychopharmacology Unit, Massachusetts General Hospital and Harvard Medical School, Boston; and Dr. Upadhyaya is with the Department of Psychiatry, Medical University of South Carolina, Charleston

Accepted 16 April 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This is a case vignette created to exemplify a complex clinical problem and does not refer to any specific patient.This column aims to discuss practical approaches to everyday issues in pediatric pharmacotherapy. The cases and discussions specifically target aspects of clinical care related to psychopharmacology for which we do not have adequate applicable controlled trials. Given the need to address symptoms in youths with complex, severe, and comorbid disorders, recommendations are likely to be “off label” from the perspective of the U.S. Food and Drug Administration. We fully appreciate that for virtually all disorders, medication is only one aspect of comprehensive care. This column focuses primarily on psychopharmacological management. The responses from the expert clinicians are not meant to be practice guidelines but rather examples of thought processes that may go into pharmacotherapy decision making.

PII: S0890-8567(09)61789-5

doi:10.1097/01.chi.0000228126.34085.79

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 45, Issue 9 , Pages 1138-1141, September 2006

Article Tools